Donate For Public and Patients Store Search

C026 - Updates in Hair Disorders

Monday, March 4; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Diagnose and manage cicatricial alopecias, alopecia areata, and androgenetic hair loss.
  • Distinguish scalp disorders by trichoscopy and scalp pathology.
  • Recognize ethnic hair disorders

Description

A wide spectrum of scalp disorders will be covered including cicatricial alopecias, androgenetic hair loss and alopecia areata. Alopecias in cancer patients and survivors will be discussed. The efficacy of the latest state of the art treatments such as platelet rich plasma and microneedling will be evaluated. Trichoscopy and scalp pathology in distinguishing scalp disorders will be emphasized. The approach to pediatric hair disorders will be elaborated. An update on surgical techniques in hair transplantation will be presented. Ethnic hair disorders in terms of recognition and treatment will be covered.

Disclosures

  • Dhurat, Rachita, MBBS, MD: no financial relationships exist with commercial interests.
  • Grimalt, Ramon, MD, PhD: no financial relationships exist with commercial interests.
  • Grimes, Pearl E., MD: Allergan, Inc. – C(H), I(Grants/Research Funding); Clinuvel – I(H); Derm Tech International – I(NC); Incyte Corporation – I(Grants/Research Funding); Laseroptek USA – I(Grants/Research Funding); Procter & Gamble Company – C(H); Suneva Medical, Inc. – I(H); VT Technologies – I(Grants/Research Funding);
  • Lacouture, Mario E., MD: AbbVie – C(H); ADC Therapeutics – C(H); Adgero Biopharmaceuticals Holdings, Inc. – C(H); Astellas Pharma US, Inc – C(H); Celldex – C(H); Galderma Research & Development, LLC – C(H); Harborside – O(Fees); Helsinn Healthcare – C(H); Johnson and Johnson – C(H); Lindiskin – C(H); Menlo Therapeutics – C(H); Merck & Co., Inc – C(H); Novartis – C(H); Novocure – C(H); Wiley & Sons, Inc. – O(Fees);
  • Mesinkovska, Natasha Atanaskova, MD, PhD: BiologicsMD, Inc. – C(H);
  • Olsen, Elise A., MD: Aclaris Therapeutics, Inc. – C(H), I(Grants/Research Funding); Allergan, Inc. – O(IP); Bioniz Therapeutics – C(H); Elorac, Inc. – I(Grants/Research Funding); Galderma USA – I(Grants/Research Funding); Helsinn Healthcare – O(H); Incyte Corporation – C(H); Lilly ICOS LLC – C(H); UpToDate, Inc – O(H);
  • Santos, Leopoldo, MD: no financial relationships exist with commercial interests.
  • Shapiro, Jerry, MD: Aclaris Therapeutics Inc. – A(H); Allergan, Inc. – A(H); Applied Biology – C(H); Bayer Consumer Healthcare Pharmaceuticals – C(NC); Bioniz Therapeutics – A(Fees); Cassiopea SpA – A(NC); Incyte Corporation – C(NC); Johnson & Johnson Consumer Products Company – C(H); L'OrĂ©al France – C(H); RegenLab – I(Grants/Research Funding); RepliCel Life Sciences – F(ST); Samumed, LLC – A(H);
  • Sperling, Leonard C., MD: no financial relationships exist with commercial interests.
  • Tosti, Antonella, MD: Aclaris Therapeutics, Inc. – A(H); Anacor Pharmaceuticals, Inc. – A(H); DS Laboratories – C(Fees); Fotofinder – C(EQ); Incyte Corporation – C(H); Kurt Wolff GmbH & Co. KG – A(H); Kythera – A(H); Meiji Seika Pharma Co., Ltd – A(H); MSD – SP(H); Novartis – A(H); PharmaDerm – Speaker/Faculty Education(H); Pierre Fabre Dermatologie – C(H); Polichem SA – A(H); Procter & Gamble Company – A(H); Springer Science & Business Media – O(IP); Taylor & Francis – O(IP); topica – C(Fees); Valeant Pharmaceuticals International – C(Fees); Viamet Pharmaceuticals, Inc – A(H);
  • Vano-Galvan, Sergio, MD, PhD: no financial relationships exist with commercial interests.
Schedule
Monday, March 4
1:00 PM
Dr. Shapiro / Cicatricial alopecias: What I do
1:15 PM
Dr. Mesinkovska / Alopecia areata 2019: What are novel treatments, what is in the pipeline and what I do now
1:30 PM
Dr. Lacouture / Alopecia in cancer patients and survivors
1:45 PM
Dr. Grimes / Ethnic hair disorders
2:00 PM
Dr. Santos / How to evaluate hair loss in women
2:15 PM
Dr. Olsen / Female Pattern Hair Loss Treatment in 2019
2:30 PM
Dr. Tosti / Dermoscopy in the evaluation and treatment of hair loss
2:45 PM
Dr. Sperling / Scalp Pathology Update
3:00 PM
Dr. Grimalt / Pediatric Hair Update
3:15 PM
Vano-Galvan / Hair Surgery Update
3:30 PM
Dr. Dhurat / Micro needling and Platelet Rich Plasma in the treatment of hair loss
3:45 PM
All faculty / Questions and Answers
Event Details
  • Date
    Monday, March 4
  • Time
    1:00 PM - 4:00 PM
  • Location
    Salon I
  • CME Credits
    3.00
  • Type
    Ticketed
Directors/Co-Directors
  • Jerry Shapiro, MD, FAAD
Speakers
  • Antonella Tosti, MD - Handout
  • Elise A. Olsen, MD, FAAD
  • Leonard C. Sperling, MD, FAAD
  • Leopoldo Santos, MD
  • Mario E. Lacouture, MD, FAAD
  • Natasha Atanaskova Mesinkovska, MD, PhD, FAAD
  • Pearl E. Grimes, MD, FAAD
  • Rachita Dhurat, MBBS, MD - Handout
  • Ramon Grimalt, MD, PhD
  • Sergio Vano-Galvan, MD, PhD - Handout